Wanrun Co., Ltd.: 2021 Annual Dividend Distribution Implementation Notice
Wanrun Co., Ltd.: Announcement on the transfer of some patent rights and patent application rights to holding subsidiaries
Wanrun Co., Ltd.: Notice on the termination of the company\'s public issuance of convertible corporate bonds and the withdrawal of application documents
Wanrun Co., Ltd.: Second Feedback Response Report on Application Documents for the Public Issuance of Convertible Corporate Bonds
Wanrun Co., Ltd.: Feedback Response Report on Application Documents for the Public Issuance of Convertible Corporate Bonds
Wanrun Co., Ltd.: Announcement on the acceptance of the public issuance of convertible corporate bonds by the Securities Regulatory Commission
Wanrun Co., Ltd.: Announcement by directors and senior management on the commitment of directors and senior management to publicly issue convertible corporate bonds with diluted immediate returns and compensation measures
Wanrun Co., Ltd.: Announcement by the controlling shareholder and actual controller on the company's commitment to publicly issue convertible corporate bonds to dilute immediate returns and compensation measures
Wanrun Co., Ltd.: Announcement on the company's public issuance of convertible corporate bonds to dilute immediate returns and compensation measures and commitments from relevant entities
Wanrun Co., Ltd.: Announcement on the completion of the acquisition of 100% of MP Biomedicals, LLC
Yantai Wanrun: Announcement on Obtaining State-owned Land Use Permits
Yantai Wanrun: Announcement on Using Some Overraised Funds to Purchase Land Use Rights and Invest in Preliminary Work on Land Infrastructure Projects
Yantai Wanrun: Announcement of Resolutions of the Seventh Meeting of the Second Board of Directors
Yantai Wanrun: Announcement of Resolutions of the Fourth Meeting of the Second Board of Supervisors
Yantai Wanrun: China Securities Regulatory Commission's Approval on Approving the Company's Initial Public Offering of Shares
No Data
No Data